MDxHealth SA, announced that it received on February 7, 2019 the following notification of significant shareholdings in accordance with the Belgian Act of May 2, 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions.
February 12, 2019
· 2 min read